FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a single-chain antibody, that binds to a cancer-embryonic antigen (CEA). Also disclosed is a chimeric monomolecular T cell receptor, comprising said antibody, a vector for expression of said receptor, a host cell producing said receptor.
EFFECT: invention has the ability specifically binds to cancer-embryonic antigen, which allows effectively treat diseases, associated with REA.
4 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SINGLE-CHAIN ANTIBODY TO CARCINOEMBRYONIC ANTIGEN, CHIMERIC MONOMOLECULAR T-CELL RECEPTOR, VECTOR AND HOST CELL FOR PROVISION OF SUCH RECEPTOR AND METHOD OF DIAGNOSTICS OR TREATMENT | 2012 |
|
RU2522004C2 |
| MONOMOLECULAR CHEMERIC T-CELLULAR RECEPTOR TO CANCER-EMBRYONIC ANTIGEN | 2015 |
|
RU2650858C2 |
| MONOMOLECULAR CHIMERIC T-CELL RECEPTOR TO CANCER ANTIGEN CA125 | 2018 |
|
RU2747095C2 |
| METHOD OF DIRECTION OF CELLULAR IMMUNE RESPONSE AGAINST HIV-INFECTED MAMMALIAN CELL, PROTEIN MEMBRANE-BOUND CHIMERIC RECEPTOR, DNA | 1995 |
|
RU2173167C2 |
| METHOD OF SUPPRESSION OF HIV-INFECTED MAMMALIAN CELLS AND PROTEIN RECOMBINANT RECEPTOR FOR ITS REALIZATION | 1995 |
|
RU2165703C2 |
| REDIRECTION OF CELLULAR IMMUNITY BY CHIMERIC RECEPTORS | 1996 |
|
RU2167676C2 |
| NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER | 2020 |
|
RU2757353C1 |
| PSCA-CAR-YT CELL LINE HAVING SURFACE EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND EXHIBITING CYTOTOXIC ACTIVITY ON PSCA-POSITIVE HUMAN CANCER CELLS | 2018 |
|
RU2712901C1 |
| TUMOR-SPECIFIC ANTI-EGFR ANTIBODY AND USE THEREOF | 2016 |
|
RU2730605C2 |
| HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
